Cardiac Risk Without a Roadmap: Lack of Evidence-Based Guidance for Cardiovascular Toxicity of T-Cell Redirecting Therapies

Current Oncology Reports · Published 2026-06-17 · DOI 10.1007/s11912-026-01791-6

Authors (5)

Serafino LaGalbo, Matthew T. Foley, Anastasia E. Metropulos, Kyle A. Burton, Daniel R. Principe

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

LaGalbo, S., Foley, M., Metropulos, A., et al. (2026). Cardiac Risk Without a Roadmap: Lack of Evidence-Based Guidance for Cardiovascular Toxicity of T-Cell Redirecting Therapies. Current Oncology Reports. https://doi.org/10.1007/s11912-026-01791-6

Related articles